Alliance for Lupus Research (ALR): Target Identification in Lupus - Letter of Intent

The ALR funds research that will accelerate the development of new treatments for lupus. As such, grant proposals should be innovative in direction and utilize state-of-the-art techniques. Fundamental studies in genetics, immunology, cell biology and molecular biology to identify and characterize molecular systems must be oriented towards the development of drugs that would prevent and/or ameliorate clinical signs and symptoms of lupus. Funding for the TIL award will be made for up to $200K/year (max 3 years: total amount up to $600K) including indirect costs. Funding for the 3-rd year is based on the successful submission of a non competitive progress report.
http://www.lupusresearch.org/research/grants.html